Dermatology is one of the most PE-targeted medical specialties in the U.S. — high margins, dual revenue streams, and a fragmented market of independent practices create a repeatable acquisition model for buyers who understand the clinical and regulatory landscape.
Find Dermatology Practice Acquisition TargetsThe U.S. dermatology services market represents approximately $20 billion in annual revenue, with thousands of independent practices still operating outside any platform structure. This fragmentation, combined with favorable demographics, an aging population driving chronic skin condition treatment, and a booming cash-pay aesthetic segment exceeding $5 billion, makes dermatology one of the most compelling roll-up opportunities in lower middle market healthcare M&A. Independent practices in the $1M–$5M revenue range are particularly attractive — they are large enough to demonstrate operational viability but small enough to be priced at accessible EBITDA multiples of 4x–7x. Buyers who can deploy a disciplined acquisition strategy, structure deals to comply with corporate practice of medicine (CPOM) laws, and retain key physicians post-close are positioned to create significant platform value before a secondary exit to a larger PE-backed group or strategic acquirer.
Dermatology stands apart from most medical specialties because of its dual revenue model: insurance-reimbursed medical dermatology services — treating acne, psoriasis, eczema, and skin cancer — combined with high-margin, cash-pay cosmetic procedures including Botox, dermal fillers, laser resurfacing, and body contouring. This combination creates a recession-resilient revenue base that holds up even when elective spending softens. Dermatologists are among the most difficult specialists to recruit due to intense residency competition, creating high barriers to entry that protect incumbent practices from new competition. Recurring patient relationships — driven by chronic conditions requiring annual or biannual visits and cosmetic patients returning for maintenance treatments — generate predictable appointment volume and strong patient lifetime value. These characteristics, combined with the industry's extreme fragmentation, give well-capitalized and operationally sophisticated acquirers a sustained window to consolidate practices at attractive entry multiples before the market matures.
The core roll-up thesis in dermatology is geographic density plus operational leverage. By acquiring three to seven independent practices within a defined metropolitan region or contiguous market, a platform buyer can centralize back-office functions — medical billing, revenue cycle management, credentialing, HR, and marketing — while allowing each clinic to retain its local brand and physician identity. This shared services model reduces per-practice overhead, improves collections on insurance claims, and enables negotiation of better payer contract rates as a larger multi-location group. The platform also gains leverage to recruit mid-level providers such as physician assistants and nurse practitioners, reducing key-person risk at each location. Critically, structuring acquisitions through a Management Services Organization (MSO) allows non-physician ownership entities to legally manage administrative operations in states with strict CPOM laws, while a physician-owned PC or professional association retains clinical authority. As the platform scales toward $5M–$15M in EBITDA, it becomes an attractive secondary exit candidate for a larger PE-backed dermatology management company or a strategic acquirer seeking geographic expansion, typically at exit multiples of 8x–12x EBITDA — a meaningful arbitrage over typical entry multiples of 4x–7x.
$1M–$5M annual revenue
Revenue Range
$800K–$2M adjusted EBITDA
EBITDA Range
Define Your Platform Thesis and Geographic Target Market
Before approaching any practice, establish a clear investment thesis: which metro area or regional cluster will anchor your platform, what mix of medical versus cosmetic dermatology revenue you are targeting, and what size practice fits your financing capacity. Buyers using SBA 7(a) financing will typically target practices with $1M–$3M in revenue for their first acquisition, while PE-backed platforms may target a larger anchor practice at $3M–$5M revenue. Clarify your MSO structure and engage a healthcare M&A attorney familiar with CPOM laws in your target state before signing any LOI.
Key focus: Market selection, investment thesis definition, MSO legal structure, and financing pre-qualification
Source and Qualify Acquisition Targets
Dermatology practices rarely list publicly. Effective sourcing requires direct outreach to retiring physician founders, engagement with healthcare-focused M&A brokers, and referrals from medical billing companies and dermatology specialty distributors who know which practices are underperforming or physician-owned by someone approaching retirement age. Qualify targets by requesting three years of P&L statements, payer mix reports, provider headcount, and malpractice history before issuing any indication of interest. Prioritize practices where the founding physician is open to a post-close employment agreement of 12–24 months to ensure patient continuity and a smooth handoff.
Key focus: Off-market sourcing, financial pre-qualification, physician retirement readiness, and deal pipeline development
Structure the LOI and Negotiate Deal Terms
Most dermatology acquisitions in the lower middle market are structured as asset purchases with an MSO overlay to comply with CPOM regulations. The physician retains ownership of the professional corporation while the MSO — owned by your platform — acquires all tangible and intangible assets and provides management services under a long-term MSA agreement. Offer structures typically include 70–80% cash at close, a seller note of 10–15%, and an earnout tied to EBITDA performance over 24–36 months. Physician equity rollover of 10–20% in the platform is a powerful retention tool and aligns the selling physician's incentives with post-close growth. Cap earnout exposure by tying payouts to metrics the seller can directly influence, such as provider productivity and cosmetic procedure volume.
Key focus: Asset purchase with MSO structure, seller note sizing, earnout design, and physician equity rollover terms
Conduct Focused Due Diligence on Clinical and Financial Risk
Dermatology due diligence must go beyond standard financial review. Commission a quality of earnings analysis that separates recurring medical dermatology revenue from discretionary cosmetic revenue and normalizes for owner compensation, personal expenses, and one-time items. Review all payer contracts for reimbursement rates, termination clauses, and change-of-control provisions that may require re-credentialing post-close. Audit malpractice claims history and confirm tail coverage obligations. Validate physician non-compete agreements for enforceability under state law — this is especially critical in states with limited enforcement of physician non-competes. Review the EMR system and billing workflows to identify integration costs and revenue cycle gaps.
Key focus: Quality of earnings, payer contract review, malpractice audit, non-compete enforceability, and EMR integration assessment
Close, Integrate, and Stabilize the First Acquisition
The 90 days post-close are the highest-risk period in any dermatology acquisition. Prioritize physician and staff retention through transparent communication, employment agreement execution, and visible operational support. Transition billing to your centralized revenue cycle management team carefully — a poorly managed billing cutover is one of the most common causes of cash flow disruption post-close. Retain the practice's local brand and patient communication style during the initial period. Begin tracking KPIs including collections per provider per day, cosmetic revenue as a percentage of total revenue, new patient acquisition rate, and payer mix composition to establish a baseline for value creation initiatives.
Key focus: Physician and staff retention, billing system transition, local brand preservation, and KPI baseline establishment
Execute Add-On Acquisitions to Build Geographic Density
Once your anchor practice is stabilized — typically 6–12 months post-close — begin acquiring add-on practices within 30–60 miles of your first location to build geographic density and justify centralized overhead. Each add-on acquisition benefits from your established MSO infrastructure, reducing integration cost and time. Add-on multiples are often lower than your platform acquisition multiple, creating immediate EBITDA accretion. Target practices where the seller is motivated by a retirement timeline, where the clinical team is already in place, and where you can layer in cosmetic revenue expansion or extended hours to drive same-store growth without significant capital investment.
Key focus: Add-on sourcing, geographic clustering, MSO leverage, EBITDA accretion, and same-store growth initiatives
Centralized Revenue Cycle Management and Billing Optimization
Independent dermatology practices frequently leave 8–15% of collectible revenue on the table due to claim denials, undercoding, and outdated billing workflows. Migrating all acquired practices to a centralized medical billing team with dermatology-specific coding expertise — CPT codes for biopsies, Mohs surgery, excisions, and cosmetic procedures — can meaningfully improve net collections within the first 12 months post-acquisition. Renegotiating payer contracts as a multi-location group further improves reimbursement rates, particularly with regional commercial insurers who prioritize network adequacy.
Cosmetic Revenue Expansion and Aesthetic Service Line Development
Medical dermatology practices with limited cosmetic offerings represent significant upside. Adding or expanding Botox, dermal fillers, laser treatments, chemical peels, and body contouring services to acquired locations increases revenue per patient visit, improves margins due to the cash-pay nature of aesthetic procedures, and attracts a younger, higher-income patient demographic. Hiring a dedicated aesthetic coordinator and investing in targeted digital marketing — before and after content, Google and social media advertising — can generate measurable cosmetic revenue growth within 90–180 days.
Mid-Level Provider Recruitment to Reduce Key-Person Risk
One of the most effective ways to increase practice capacity and reduce dependence on a single physician is to add licensed PA or NP providers trained in dermatology. Mid-level providers can independently manage medical dermatology visits for conditions like acne, eczema, and minor procedures, freeing the supervising dermatologist to focus on complex cases, Mohs surgery, and high-margin cosmetic consultations. This provider leverage model increases total patient throughput, reduces scheduling bottlenecks, and lowers the platform's exposure to any single physician's departure or disability.
Technology Modernization and EMR Standardization
Standardizing all acquired practices on a single cloud-based EMR and practice management platform — such as Modernizing Medicine (EMA), Nextech, or Athenahealth — creates operational efficiency, simplifies compliance reporting, enables centralized analytics, and reduces IT support costs. A unified technology stack also makes the platform significantly more attractive to a future acquirer or PE sponsor who will want clean, consolidated data for financial reporting, provider productivity benchmarking, and payor analytics.
Brand Investment and Digital Patient Acquisition
Most independent dermatology practices underinvest in digital marketing, relying on physician referrals and organic search traffic. A platform-level investment in SEO, Google Business Profile optimization, online review management, and targeted paid advertising for cosmetic services can substantially increase new patient volume across all locations. A centralized patient communication platform enabling online booking, automated appointment reminders, and post-visit follow-up improves patient retention, reduces no-show rates, and increases cosmetic treatment conversion from medical dermatology patients already in the practice.
A well-constructed dermatology roll-up platform with $5M–$15M in EBITDA and four to eight locations in a defined geographic market is a highly sought secondary exit candidate. The most likely buyers are large PE-backed dermatology management companies — such as national or super-regional platforms seeking to add geographic density — or strategic acquirers including hospital systems and large multispecialty groups expanding their dermatology footprint. Exit multiples at this scale typically range from 8x–12x EBITDA, compared to entry multiples of 4x–7x on individual practice acquisitions, generating meaningful multiple arbitrage in addition to organic EBITDA growth. To maximize exit value, platform operators should prioritize three to four years of consistent same-store revenue growth, a cosmetic revenue mix above 30% of total collections, at least two dermatologists per location on average, and a clean compliance record with no unresolved malpractice claims or regulatory issues. Engaging a healthcare-focused investment bank 12–18 months before a planned exit allows time to run a competitive sale process, prepare a compelling confidential information memorandum highlighting the dual revenue model and geographic clustering thesis, and negotiate favorable representations and warranties insurance terms that protect both buyer and seller at close.
Find Dermatology Practice Roll-Up Targets
Signal-scored acquisition targets matched to your roll-up criteria.
No, non-physicians can acquire and operate dermatology practices in most states, but the ownership and deal structure must comply with corporate practice of medicine (CPOM) laws. In states with strict CPOM statutes — including California, Texas, and New York — a non-physician cannot directly own a medical professional corporation. The standard solution is an MSO structure: a non-physician-owned management services organization acquires all business assets and manages administrative operations under a long-term management services agreement, while a physician-owned professional corporation retains legal authority over clinical decisions and employs the medical staff. Engaging a healthcare M&A attorney familiar with CPOM laws in your target state before structuring any offer is essential.
Independent dermatology practices in the $1M–$5M revenue range typically trade at 4x–7x adjusted EBITDA, depending on practice quality, revenue mix, provider count, and market location. Practices with strong cosmetic revenue, multiple providers, and diversified payer mix command the higher end of that range. Single-physician practices with heavy Medicare concentration and minimal cosmetic revenue will trade closer to 4x–5x. As your platform scales toward $5M+ in EBITDA, your exit multiple as a platform will typically be 8x–12x, creating the multiple arbitrage that is central to the roll-up value creation thesis.
Physician retention is the single highest-risk element of any dermatology acquisition. The most effective retention tools are a competitive post-close employment agreement — typically 12–24 months minimum — with market-rate compensation, a meaningful equity rollover stake in the platform (10–20% is common), and an earnout tied to practice-level EBITDA that rewards the physician for staying engaged. Beyond financial structure, cultural fit matters: physicians are more likely to stay and refer within the platform if they feel their clinical autonomy is preserved, their staff is treated well, and the acquiring entity is not imposing disruptive operational changes in the first year post-close.
Cosmetic revenue is a significant value driver in dermatology M&A because it is cash-pay, carries higher margins than insurance-reimbursed medical services, and is not exposed to reimbursement rate compression from Medicare or commercial payers. A practice generating 30–50% of total revenue from cosmetic procedures — Botox, fillers, laser, and body contouring — will typically command a higher EBITDA multiple and attract more competitive buyer interest than a purely medical dermatology practice. Sellers should document and segment cosmetic versus medical revenue clearly in their financial records, and buyers should underwrite cosmetic revenue conservatively to account for provider dependency and patient loyalty risks.
The most common deal-killers in dermatology acquisitions are: a single physician driving 80% or more of revenue with no succession plan or willingness to sign a post-close employment agreement; pending or unresolved malpractice claims or state medical board disciplinary actions; heavy Medicare and Medicaid concentration above 50% combined, which signals reimbursement risk; inconsistent or declining revenue trends over the trailing three years with no credible growth narrative; and a facility lease expiring within 12 months with no renewal option or a landlord unwilling to consent to assignment. Buyers should screen for all of these issues during initial qualification before committing to full due diligence costs.
Yes, dermatology practices are generally eligible for SBA 7(a) financing, making it one of the most accessible financing options for independent buyer-operators acquiring their first or second practice. SBA loans can fund up to 90% of the purchase price on qualifying transactions, with the remaining 10% typically covered by a seller note or buyer equity injection. Key eligibility requirements include the buyer being a U.S. citizen or permanent resident, the business meeting SBA small business size standards, and the loan being for an eligible purpose such as a business acquisition. Buyers using SBA financing should expect to provide a personal guarantee and demonstrate relevant management or healthcare industry experience. Working with an SBA-preferred lender with healthcare M&A experience will significantly accelerate the approval timeline.
More Dermatology Practice Guides
More Roll-Up Strategy Guides
Build your platform from the best Dermatology Practice operators on the market — free to start.
Create your free accountNo credit card required
For Buyers
For Sellers